Announcement on Obtaining the Drug Registration Certificate for Ipratropium Bromide Solution for Inhalation
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining the Drug Registration Certificate for Ipratropium Bromide Solution for Inhalation
Filed with SSE · · 2 pages · Chinese
Release
Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Hainan Huluwa Pharmaceutical
- Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution
- Announcement on Expected Loss in Performance for 2025
- Announcement on Providing Guarantee for Wholly-owned Subsidiary by Guangxi Weiwei Pharmaceutical Co., Ltd.
- Indicative Announcement on Upcoming Judicial Auction of Some Shares Held by Controlling Shareholder
- Announcement on Obtaining Drug Registration Certificate for Levosalbutamol Hydrochloride Nebuliser Solution
Later from Hainan Huluwa Pharmaceutical
- Announcement on Progress in Judicial Auction of Some Shares Held by Controlling Shareholder
- Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Ambroxol Hydrochloride Oral Drops
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Progress in Implementing Other Risk Warnings for the Company's Stocks
- Announcement on Company Re-certified as High-tech Enterprise
Follow Hainan Huluwa Pharmaceutical into a list and get an email when it puts out news.
Follow Hainan Huluwa Pharmaceutical